Dr. Tara Karnezis – CEO, Managing Director
Dr Karnezis has over 15 years’ experience in research leadership, heading scientific programs with commercial application at Stanford University and Peter Mac. She is an expert in vascular biology with an internationally significant track record including publications in Nature, Cancer Cell and Nature Neuroscience. Dr Karnezis authored the seminal Nature paper that described Sox18 as the master-regulator of lymphatic vessel development. In addition to experience with target identification and validation, she has been involved in identifying druggable targets related to the interaction of vascular biology and oncology.